CBT
CLB icon

Capital Bank & Trust’s Core Laboratories CLB Stock Holding History

Capital Bank & Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-148
Closed -$8K – 800
2019
Q2 		$8K Buy
148
+33
+29% +$1.94K ﹤0.01% 558
2019
Q1 		$8K Sell
115
-59
-34% -$3.96K ﹤0.01% 546
2018
Q4 		$10K Buy
174
+62
+55% +$5.35K ﹤0.01% 563
2018
Q3 		$13K Buy
+112
New +$12.6K ﹤0.01% 635

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Bank & Trust's CLB Position: Q3 2019 in Review

Capital Bank & Trust sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 148 shares — an estimated $8K sold.

Capital Bank & Trust first reported a position in CLB in Q3 2018 and held it in 4 quarters. The position peaked at $13K in Q3 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

  • Capital Bank & Trust reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 148 Core Laboratories shares in Q3 2019, an estimated $8K.
  • Capital Bank & Trust first reported a position in Core Laboratories in Q3 2018 and held it in 4 quarters.
  • Capital Bank & Trust's Core Laboratories position peaked at $13K in Q3 2018.
  • 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on Capital Bank & Trust's 13F filing for Q3 2019, filed 14 Nov 2019.